IP Library › Granted Patent US 6,998,107
Granted Patent B2
US 6,998,107 · App. 10/864,965 · Granted Feb 14, 2006

Composition comprising low density microspheres

Assignee: Bristol-Myers Squibb Pharma Comapany
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,998,107
App. No.
10/864,965
Granted
Feb 14, 2006
Kind
B2
Abstract

Low density microspheres, methods for preparing same, and use of same as contrast agents are described. The microspheres have a void having a volume that comprises at least about 75% of the total volume of the microspheres, and which contains a gas or the vapor of a volatile liquid selected from the group consisting of aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes and perfluorocarbons.

Claims (9)

1. A composition comprising low density microspheres having an outside diameter of from about 5 to about 70 microns, said microspheres comprising a polymer and having a void containing the vapor of a volatile liquid perfluorocarbon, wherein said microspheres, when combined with an aqueous solution to form a contrast agent, are suitable for administration to a patient either orally, rectally or by injection.

2. A composition according to claim 1 wherein said polymer comprises a synthetic polymer or copolymer prepared from the group of monomers consisting of acrylic acid, methacrylic acid, ethyleneimine, crotonic acid, acrylamide, ethyl acrylate, methyl methacrylate, 2-hydroxyethyl methacrylate, lactic acid, glycolic acid, ε-caprolactone, acrolein, cyanoacrylate, bisphenol A, epichlorhydrin, hydroxyalkylacrylates, siloxane, dimethylsiloxane, ethylene oxide, ethylene glycol, hydroxyalkyl-methacrylates, N-substituted acrylamides, N-substituted methacrylamides, N-vinyl-2-pyrrolidone, 2,4-pentadiene-1-ol, vinyl acetate, acrylonitrile, styrene, p-amino-styrene, p-amino-benzyl-styrene, sodium styrene sulfonate, sodium 2-sulfoxyethyl methacrylate, vinyl pyridine, aminoethyl methacrylates, 2-methacryloyloxy-trimethylammonium chloride, N,N′-methylenebisacrylamide, ethylene glycol dimethacrylates, 2,2′-(p-phenylenedioxy)-diethyl dimethacrylate, divinylbenzene, triallylamine, and methylenebis-(4-phenyl-isocyanate).

3. A composition according to claim 2 wherein said microspheres comprise synthetic polymers or copolymers prepared from the group of monomers consisting of acrylic acid, methacrylic acid, ethyleneimine, crotonic acid, acrylamide, ethyl acrylate, methyl methacrylate, 2-hydroxyethyl methacrylate, lactic acid, glycolic acid, ε-caprolactone, acrolein, cyanoacrylate, bisphenol A, epichlorhydrin, hydroxyalkylacrylates, siloxane, dimethylsiloxane, ethylene oxide, ethylene glycol, hydroxyalkyl-methacrylates, N-substituted acrylamides, N-substituted methacrylamides, N-vinyl-2-pyrrolidone, 2,4-pentadiene-1-ol, vinyl acetate, acrylonitrile, styrene, p-amino-styrene, p-amino-benzyl-styrene, sodium styrene sulfonate, sodium 2-sulfoxyethylmethacrylate, vinyl pyridine, aminoethyl methacrylates, and 2-methacryloyloxy-trimethylammonium chloride.

4. A composition according to claim 1 wherein said microspheres comprise synthetic polymers or copolymers selected from the group consisting of polyacrylic acid, polyethyleneimine, polymethacrylic acid, polymethylmethacrylate, polysiloxane, polydimethylsiloxane, polylactic acid, poly(ε-capro-lactone), epoxy resin, poly(ethylene oxide), poly(ethylene glycol), polyamide, polyvinylidene-polyacrylonitrile, polyvinylidene-poly-acrylonitrile-polymethylmethacrylate, and polystyrene-polyacrylonitrile.

5. A composition according to claim 1 wherein said microspheres are prepared by a heat expansion process.

6. A composition according to claim 1 where said perfluorocarbon has between 1 and about 9 carbon atoms and between 4 and about 20 fluorine atoms.

7. A composition according to claim 6 wherein said perfluorocarbon has between 1 and 4 carbon atoms and between 4 and 10 fluorine atoms.

8. A composition according to claim 6 wherein said perfluorocarbon has between 4 and about 9 carbon atoms and between 10 and about 20 fluorine atoms.

9. A composition according to claim 6 wherein said perfluorocarbon is C 4 F 10 .

Assignments (12)
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS Recorded Mar 30, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: LANTHEUS HOLDINGS, INC.; LANTHEUS MEDICAL IMAGING, INC.; LANTHEUS MI REAL ESTATE, LLC
Reel/Frame 042115/0715 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS Recorded Jul 3, 2013
From: BMO HARRIS BANK N.A.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ASSIGNEE
Reel/Frame 030740/0335 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded May 13, 2010
From: ABLECO FINANCE LLC
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 024380/0363 →
SECURITY AGREEMENT Recorded May 13, 2010
From: LANTHEUS MEDICAL IMAGING, INC.
To: HARRIS N.A., AS COLLATERAL AGENT
Reel/Frame 024390/0733 →
CHANGE OF NAME Recorded Oct 26, 2009
From: DUPONT CONTRAST IMAGING INC.
To: BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC.
Reel/Frame 023420/0088 →
CONFIRMATORY ASSIGNMENT Recorded Oct 26, 2009
From: UNGER, EVAN C.
To: IMARX PHARMACEUTICAL CORP.
Reel/Frame 023420/0081 →
CHANGE OF NAME Recorded Oct 26, 2009
From: IMARX PHARMACEUTICAL CORP.
To: DUPONT CONTRAST IMAGING INC.
Reel/Frame 023420/0094 →
MERGER Recorded Oct 26, 2009
From: IMARX PHARMACEUTICAL CORP.
To: DUPONT CONTRAST IMAGING INC.
Reel/Frame 023420/0111 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2009
From: UNGER, EVAN C.
To: IMARX PHARMACEUTICAL CORP.
Reel/Frame 023420/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2009
From: UNGER, EVAN C.
To: IMARX PHARMACEUTICAL CORP.
Reel/Frame 023157/0760 →
CHANGE OF NAME Recorded Mar 6, 2008
From: BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 020609/0497 →
GRANT OF SECURITY INTEREST Recorded Jan 17, 2008
From: BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC.
To: ABLECO FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 020371/0523 →
Continuity (9)
Continuation 1028084400 · Oct 25, 2002
Continuation 0887823300 · Jun 18, 1997
Continuation 0859426900 · Jan 30, 1996
Division 0845673800 · Jun 1, 1995
Division 0844909000 · May 24, 1995
Division 0811698200 · Sep 7, 1993
Division 0798059400 · Jan 19, 1993
Division 0768098400 · Apr 5, 1991
Related Publication 20040223914A1 · Nov 11, 2004